| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0004 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |